 |
 |
Sales/Operating income/Ordinary income/Net
income for the year |
 |
 |
 |
| Consolidated data (in unit of million yen) |
'07/3 |
'08/3 |
'09/3 |
'10/3 |
'11/3 |
| Sales |
31,444 |
29,112 |
20,796 |
18,221 |
20,984 |
| Operating income |
2,094 |
796 |
- 2,008 |
683 |
1,325 |
| Ordinary income |
2,173 |
763 |
- 1,721 |
654 |
1,241 |
| Net income for the year |
17 |
- 1,164 |
- 7,188 |
256 |
306 |
|
|


 |
Total assets/Net Assets/Equity capital ratio |
 |
 |
 |
| Consolidated data (in unit of million yen) |
'07/3 |
'08/3 |
'09/3 |
'10/3 |
'11/3 |
| Total assets |
49,409 |
42,863 |
32,500 |
32,312 |
31,361 |
| Net Assets |
44,494 |
38,351 |
28,521 |
28,546 |
27,930 |
| Equity capital ratio |
89.6% |
89.0% |
87.2% |
87.5% |
88.5% |
|
|
|
 |
Cash flow |
 |
 |
 |
| Consolidated data (in unit of million yen) |
'07/3 |
'08/3 |
'09/3 |
'10/3 |
'11/3 |
| Cash flow from operating activities |
3,407 |
3,467 |
1,686 |
- 377 |
2,409 |
| Cash flow from investing activities |
- 2,407 |
- 3,218 |
- 1,776 |
- 1,011 |
- 1,134 |
| Cash flow from financial activities |
- 2,282 |
- 3,739 |
- 1,986 |
- 398 |
- 237 |
| Cash and cash equivalents at end of year |
19,761 |
16,073 |
13,883 |
12,019 |
12,849 |
| Free cash flow |
999 |
249 |
- 90 |
- 1,389 |
- 1,274 |
|
|

 |
Facility investment/Depreciation/Research and development cost |
 |
 |
 |
| Consolidated data (in unit of million yen) |
'07/3 |
'08/3 |
'09/3 |
'10/3 |
'11/3 |
| Facility investment (Tangible fixed assets) |
1,732 |
2,715 |
1,440 |
742 |
1,237 |
| Depreciation |
2,715 |
2,757 |
2,577 |
1,377 |
1,398 |
| Research and development cost |
1,297 |
1,238 |
1,006 |
452 |
525 |
|
|
|
 |
|
 |
 |
| |
| |

|
 |
|
 |